| Symbol | Name | Last Close | Mkt Cap | DailyStocks' Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
|
Vote Now! Friday’s Close |
|---|---|---|---|---|---|
| TEVA | Teva Pharmaceutical Industries Limited | $23.43 | $23.86B | N/A |
Teva launches Rituxan biosimilar in U.S.
https://seekingalpha.com/news/3568193-teva-launches-rituxan-biosimilar-in-u-s?source=feed_sector_healthcare
May 04, 2020 - Teva Pharmaceutical Industries (NYSE:TEVA) and collaboration partner Celltrion Healthcare announce the commercial availability of Truxima (rituximab-abbs), a biosimilar to Roche's (OTCQX:RHHBY) Rituxa
0
Teva Charged In Criminal Antitrust Investigation: What It Means
https://seekingalpha.com/article/4372214-teva-charged-in-criminal-antitrust-investigation-what-means?source=feed_tag_israel
Sep 02, 2020 - One week ago, the DOJ charged Teva for overcharging customers in an alleged price-fixing conspiracy. In this article, I will take a closer look at what this lawsuit means for Teva.
0
Teva Pharmaceuticals Near 20-Year Lows
https://seekingalpha.com/article/4332825-teva-pharmaceuticals-near-20-year-lows?source=feed_tag_israel
Mar 18, 2020 -
0
Teva Pharmaceutical Industries Ltd. (TEVA) Gains But Lags Market: What You Should Know
http://www.zacks.com/stock/news/837115/teva-pharmaceutical-industries-ltd-teva-gains-but-lags-market-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-837115
Mar 26, 2020 - Teva Pharmaceutical Industries Ltd. (TEVA) closed the most recent trading day at $7.90, moving +0.77% from the previous trading session.
0
Teva Pharmaceutical Industries Ltd. (TEVA) Gains As Market Dips: What You Should Know
http://www.zacks.com/stock/news/897134/teva-pharmaceutical-industries-ltd-teva-gains-as-market-dips-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v1-897134
Apr 28, 2020 - In the latest trading session, Teva Pharmaceutical Industries Ltd. (TEVA) closed at $10.84, marking a +1.12% move from the previous day.
0
Novartis Reports Data on Inclisiran, CHMP Positive on Zolgensma
http://www.zacks.com/stock/news/845181/novartis-reports-data-on-inclisiran-chmp-positive-on-zolgensma?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-845181
Mar 30, 2020 - Novartis (NVS) announces pipeline updates on inclisiran and regulatory updates on Cosentyx and Zolgensma.
0
Teva Pharmaceutical Industries Ltd. (TEVA) Gains As Market Dips: What You Should Know
http://www.zacks.com/stock/news/859627/teva-pharmaceutical-industries-ltd-teva-gains-as-market-dips-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v1-859627
Apr 07, 2020 - Teva Pharmaceutical Industries Ltd. (TEVA) closed at $9.54 in the latest trading session, marking a +0.85% move from the prior day.
0
Is a Beat in Store for Perrigo (PRGO) This Earnings Season?
http://www.zacks.com/stock/news/891904/is-a-beat-in-store-for-perrigo-prgo-this-earnings-season?cid=CS-ZC-FT-analyst_blog|earnings_preview-891904
Apr 27, 2020 - Perrigo's (PRGO) Consumer Self Care Americas segment is expected to have aided the company's top line in the soon-to-be-reported quarter.
0
Satsuma Plunges on Disappointing Data on Migraine Treatment
http://www.zacks.com/stock/news/1057087/satsuma-plunges-on-disappointing-data-on-migraine-treatment?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-1057087
Sep 11, 2020 - Satsuma (STSA) tanks as late-stage study of STS101 (dihydroergotamine [DHE] nasal) powder as an acute treatment for migraine disappoints.
0
Pages: 12
<Page 2